{"id":"559126-7488","orgnr":"559126-7488","name":"DoN Pharma AB","name_registered_on":"2017-09-26","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2017-09-26","business_description":"Aktiebolaget ska bedriva läkemedelsutveckling, medicinsk konsultverksamhet och därmed förenad verksamhet.","industries":[{"code":"72109","name":"Annan naturvetenskaplig och teknisk forskning och utveckling"}],"postal_address":{"street":"LÅNGÄNGSVÄGEN, 53","care_of":"c/o Dag Linnarsson","postal_code":"18275","city":"STOCKSUND","country":"SE","municipality":{"code":"0162","name":"Danderyd"},"county":{"code":"01","name":"Stockholms län"}},"registered_office":{"municipality":{"code":"0162","name":"Danderyd"},"county":{"code":"01","name":"Stockholms län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"0","name":"< 1 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"never_registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"K2","signed_on":"2025-05-18","documents":{"annual_report":"/v1/documents/eb9b66d0-1d3b-4dd9-9818-dbdfef4edae8.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/23_7.zip"}},{"from":"2024-01-01","to":"2024-12-31","framework":"K2","signed_on":"2025-06-30","documents":{"annual_report":"/v1/documents/bde64179-3004-4864-bb2d-3bfba2640d82.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/27_10.zip"}},{"from":"2023-01-01","to":"2023-12-31","framework":"K2","signed_on":"2024-06-28","documents":{"annual_report":"/v1/documents/42607de9-e823-4846-943a-67c547895219.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/28_5.zip"}},{"from":"2022-01-01","to":"2022-12-31","framework":"K2","signed_on":"2023-06-29","documents":{"annual_report":"/v1/documents/f436cea5-267e-43e7-a113-9d4079a8ed25.xhtml"},"source":{"dataset":"arsredovisningar","file":"2023/29_4.zip"}},{"from":"2021-01-01","to":"2021-12-31","framework":"K2","signed_on":"2022-06-28","documents":{"annual_report":"/v1/documents/c7edc78d-42f9-4c5b-b64b-edaf3238026a.xhtml"},"source":{"dataset":"arsredovisningar","file":"2022/29_3.zip"}},{"from":"2020-01-01","to":"2020-12-31","framework":"K2","signed_on":"2021-05-24","documents":{"annual_report":"/v1/documents/7045b704-1b02-4a29-925d-b2c5f9d3da7a.xhtml"},"source":{"dataset":"arsredovisningar","file":"2021/21_2.zip"}},{"from":"2019-01-01","to":"2019-12-31","framework":"K2","signed_on":"2020-06-30","documents":{"annual_report":"/v1/documents/aca9bbed-f80a-4fc8-831d-0cb695151304.xhtml"},"source":{"dataset":"arsredovisningar","file":"2020/29_2.zip"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"company","currency":"SEK","net_sales":0,"operating_profit":-27539,"profit_after_financial_items":-27491,"net_profit":-27491,"total_assets":1060938,"current_assets":17163,"equity":176305,"share_capital":50000,"unrestricted_equity":126305,"current_liabilities":884633,"cash":10421,"equity_ratio":0.17,"net_sales_growth":-1,"source":{"annual_report":"2025-12-31","document":"/v1/documents/eb9b66d0-1d3b-4dd9-9818-dbdfef4edae8.xhtml"},"anchors":{"cash":{"text":"10 421","prefix":"Summa kassa och bank","suffix":"3 568"},"current_assets":{"text":"17 163"},"current_liabilities":{"text":"884 633"},"equity":{"text":"176 305"},"equity_ratio":{"text":"17","prefix":"Soliditet (%)"},"net_sales":{"text":"0","prefix":"Nettoomsättning","suffix":"23"},"operating_profit":{"text":"27 539","suffix":"-91"},"profit_after_financial_items":{"text":"27 491","suffix":"-91"},"share_capital":{"text":"50 000","prefix":"utgång"},"total_assets":{"text":"1 060 938","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"126 305","prefix":"491"}}},"officers":{"annual_report":"2025-12-31","signed_on":"2025-05-18","signatories":[{"name":"D*****"}]}}